Table 1.
VACV ORFsa | VACV epitopesb | ECTVc | Recognition by | ||
---|---|---|---|---|---|
VACV-reactive T cellsb,d | ECTV-reactive T cellse | hu PBMCsf | |||
D1R808–817 | RPSTRNFFEL | • | + | + | + |
A34R82–90 | LPRPDTRHL | • | + | + | – |
D1R686–694 | HPRHYATVM | • | + | + | + |
J6R303–311 | MPAYIRNTL | • | + | + | + |
F4L6–14 | APNPNRFVI | • | + | + | – |
E2L216–224 | RPRDAIRFL | • | + | + | + |
A3L192–200 | SPSNHHILL | • | + | + | + |
D5R375–383 | LPKEYSSEL | • | + | + | – |
L4R37–45 | FPRSMLSIF | • | + | + | + |
E9L526–534 | FPYEGGKVF | • | + | + | + |
I6L282–291 | IPKKIVSLL | • | – | + | – |
B15R91-101 | IPDEQKTIIGL | • | – | + | – |
D9R26-35 | IPRSKDTHVF | • | – | + | – |
A24R1002-1010 | KPYASKVFF | • | – | + | – |
B8R70–78 g | FPKNDFVSF | K72N | + | – | + |
N2L104–113 | RPNQHHTIDL | Q107K | + | – | + |
O1L335–344 | RPMSLRSTII | NSH | + | – | + |
A4L126–135 | APASSLLPAL | NSH | – | – | + |
B22R72-80 | TVADVRHCL | NSH | – | – | + |
E9L175–183 | FPSVFINPI | • | – | – | + |
A11R22–30 | YPSNKNYEI | • | – | nt | + |
A20R162–170 | IPKYLEIEI | • | – | nt | + |
C19L/B25R78–86 | NPSVLKILL | N78K | – | nt | + |
E5R131-1–40 | NPSKMVYALL | • | – | nt | + |
G2R140-149 | VPITGSKLIL | NSH | – | nt | + |
I6L237–245 | FPTNTLTSI | • | + | nt | – |
I6L282–291 | LPSNVEIKAI | • | – | nt | + |
aOpen reading frames and location of epitopes defined based on Copenhagen reference strain (VACCC, ID 10,249).
bVACV-derived epitopes recognised by CD8+ T cells reported by us and others in mice and humans20.
cAmino acid changes in the orthologous ECTV peptide; •, conserved sequences with 100% homology; NSH, no significant homology; based on Netblast (blastcl3: www.ncbi.nlm.nih.gov) using ECTV txid12643.
dB7.2tg mouse CD8+ T cells that react to VACV20.
eB7.2tg mouse CD8+ T cells that react to ECTV (this study): + , positive response (see Fig. 2); –, no response; nt, not tested.
fhu, VACV-reactive CD8+ T cells in human PBMC20.
gB8R orthologue in ECTV is C4R based on Netblast using ECTV txid12643.